Uniform Determination of Death Act and brain death

The Uniform Determination of Death Act (UDDA) is a model U.S. law, promulgated in 1981, that provides a uniform legal standard for determining when a person is dead.[1][2] It states that an individual is dead who has sustained either (1) irreversible cessation of circulatory and respiratory functions, or (2) irreversible cessation of all functions of the entire brain, including the brainstem, the second criterion being known as the whole-brain standard of death, or brain death (clinically, "brain death / death by neurologic criteria," BD/DNC).[1][2] The UDDA specifies that a determination of death must be made "in accordance with accepted medical standards," leaving the clinical criteria to the medical profession rather than fixing them in statute.[1][2] Some version of a brain-death statute has been adopted in every U.S. state, though wording and accommodation provisions vary.[2][3]

Brain death is legally and clinically distinct from a coma or a persistent vegetative state, in which some brain function remains, and from donation after circulatory death (DCD), in which death is determined by circulatory criteria.[1][2] Because the determination of death is the legal predicate for deceased organ recovery under the dead donor rule, the standard for death is closely connected to organ donation, although the determination of death is made independently of any donation decision.[2][4] The whole-brain standard and the ongoing effort to revise the UDDA are the subject of genuine scholarly and legal controversy, summarized below with attention to the range of published views.

The UDDA (1981)

The UDDA was drafted in 1981 by a task force convened with the participation of the American Bar Association, the American Medical Association, and the National Conference of Commissioners on Uniform State Laws (now the Uniform Law Commission, ULC), and was endorsed by the President's Commission for the Study of Ethical Problems in Medicine.[1][2] Its central move was to make death determined by neurologic criteria the legal equivalent of death determined by circulatory-respiratory criteria, so that a person who has irreversibly lost all functions of the entire brain is legally dead even while a ventilator maintains circulation and breathing mechanically.[1][2]

The Act's text provides two alternative criteria, circulatory-respiratory or whole-brain, and a single instruction that the determination be made by accepted medical standards.[1][2] By deferring the clinical detail to the medical profession, the UDDA separated the legal definition of death (a fixed statutory standard) from the medical tests used to confirm it (which evolve with guidelines).[1][2]

Adoption

A brain-death standard, generally modeled on the UDDA, has been adopted in all U.S. states, whether by enacting the UDDA itself, an earlier model act, or a state-specific statute.[2][3] However, states differ in important respects, particularly in whether and how they accommodate religious or moral objection to the neurologic standard (see Controversies, below).[3][5]

Determining brain death (clinical criteria)

Because the UDDA defers to "accepted medical standards," the clinical criteria are set by professional guidelines rather than by the statute.[1][2] In the United States the current reference standard is the 2023 consensus practice guideline issued jointly by the American Academy of Neurology (AAN), the American Academy of Pediatrics (AAP), the Child Neurology Society (CNS), and the Society of Critical Care Medicine (SCCM), published in Neurology in October 2023.[6][7] It updated and merged the previous adult (2010) and pediatric (2011) guidelines into a single document spanning infants, children, and adults.[6][7]

Determination of brain death proceeds in defined steps:[2][6]

• Prerequisites. The clinician must establish an irreversible, identifiable cause of catastrophic brain injury and exclude confounders, including drug intoxication or sedation, neuromuscular blockade, severe metabolic or endocrine derangement, and hypothermia; the guideline specifies thresholds such as an adequate core temperature, an adequate systolic blood pressure, and sufficient clearance of confounding drugs before testing.[2][6]
• Clinical examination. The examination must demonstrate coma (no responsiveness), absence of all brainstem reflexes (pupillary, corneal, oculocephalic and oculovestibular/cold-caloric, gag, and cough reflexes), and absence of any motor response to noxious stimulation.[2][6]
• Apnea testing. With the patient preoxygenated and disconnected from the ventilator, the clinician observes for any spontaneous respiratory effort while carbon dioxide accumulates. The 2023 guideline sets targets including a PaCO2 of at least 60 mm Hg and at least 20 mm Hg above baseline, and, a notable addition relative to earlier guidance, an arterial pH below 7.3; absence of respiratory effort at those targets is consistent with brain death.[2][6][7] The test is aborted if the patient becomes hemodynamically unstable or desaturates.[2][6]
• Ancillary testing. When components of the clinical examination or apnea test cannot be performed or are confounded, ancillary tests are used to support the determination, including studies of cerebral blood flow (such as catheter cerebral angiography, considered a reference standard for blood flow, radionuclide perfusion imaging, or CT/MR angiography) or, in some protocols, electrophysiologic studies.[2][6]

The guideline also addresses who may perform the determination and how many examinations are required, which differs in some respects between adults and children.[6][7]

Brain death and organ donation

Death determined by neurologic criteria is the basis for donation after brain death (DBD), historically the source of most transplanted organs, because the donor's circulation and oxygenation can be maintained mechanically after death is declared, preserving organ function until recovery.[2][4] This is distinct from donation after circulatory death (DCD), in which the donor has not met neurologic criteria and death is instead determined by the irreversible cessation of circulation after withdrawal of life-sustaining treatment.[2][4] In both pathways, the determination of death is made by the treating team independently of the donation decision and the transplant team, an independence that underlies the dead donor rule.[2][4] The clinical sequence of deceased donation is described in The donation pathway.

Controversies and the UDDA revision effort

The whole-brain standard and the UDDA are the subject of ongoing debate among clinicians, ethicists, and legal scholars. The encyclopedia presents the principal positions without endorsing any of them.

Coherence of the whole-brain standard

Critics have argued that the UDDA's statutory phrase "all functions of the entire brain" does not match what accepted medical tests actually confirm.[8][9] The most cited example is hypothalamic-pituitary (neuroendocrine) function: some patients who meet clinical brain-death criteria retain hypothalamic function, such as antidiuretic-hormone secretion, which is generally not tested in standard brain-death protocols.[8][9] On this view, "all functions of the entire brain" is read literally, the clinical standard does not strictly satisfy it; defenders respond that the relevant standard is the irreversible loss of the brain's integrative capacity for consciousness and spontaneous breathing, which the clinical tests do confirm, and that isolated cellular or hormonal activity does not constitute a "function of the brain" in the sense the Act intends.[8][9] A related dispute concerns whether "irreversible" should be replaced with "permanent," and how the circulatory-respiratory criterion should be interpreted, particularly in DCD.[8][9]

Litigated cases and religious or moral objection

Several cases have brought these questions into the courts and into public view. The most prominent is the case of Jahi McMath, a 13-year-old declared brain dead in California in December 2013 after surgical complications; her family contested the determination on religious grounds, obtained court orders to continue mechanical support, and ultimately moved her to New Jersey, where she was treated as a living patient until her death in June 2018 from unrelated complications.[5][10] States differ in how they handle such objection: New Jersey's statute (N.J.S.A. 26:6A-5) is the only U.S. statute that fully exempts an individual from the neurologic standard when it conflicts with sincerely held religious beliefs, requiring death in that situation to be determined by cardiorespiratory criteria; California, New York, and Illinois require hospitals to make reasonable efforts to accommodate religious or moral objection without overriding the neurologic standard itself.[3][5][10] This state-to-state variation produces the often-noted result that an identical clinical condition can be legally "dead" in one state and "alive" in another.[3][5]

The ULC revision effort (2021-)

In 2021, the Uniform Law Commission convened a drafting committee to consider revising the UDDA, prompted by published concerns from clinicians and ethicists about ambiguities in the dual criteria, the gap between the statutory "all functions" language and accepted clinical tests (including the hypothalamic-function objection), and the interpretation of "irreversible."[8][9][11] The committee's work surfaced deep disagreement, including over whether and how to define which brain functions matter, how to handle religious accommodation, and whether revising the statute could resolve what are ultimately philosophical disputes about the definition of death, and the effort did not produce an adopted revised act, with participants describing why the attempt stalled.[9][11] As of mid-2026 the UDDA remains in its 1981 form and the revision question is unresolved; this is a moving target and the status of any future ULC action should be re-confirmed against the Commission's materials.[9][11]

See also

• The dead donor rule
• Deceased donation
• The donation pathway
• Uniform Anatomical Gift Act (UAGA)
• Organ donation

References

• Uniform Determination of Death Act (1981). Uniform Law Commission / National Conference of Commissioners on Uniform State Laws. (Model act; text and history.) https://www.uniformlaws.org/
• Brain Death Criteria. StatPearls. NBK545144 / NBK538159. https://www.ncbi.nlm.nih.gov/books/NBK538159/
• Lewis A, et al. State variation in brain-death determination and religious accommodation. (Overview of state statutes including N.J.S.A. 26:6A-5; CA, NY, IL accommodation.) See also Qz/legal analyses. https://pmc.ncbi.nlm.nih.gov/articles/PMC6092846/
• The Dead Donor Rule and organ donation (neutral overview). PMC8283419. https://pmc.ncbi.nlm.nih.gov/articles/PMC8283419/
• Frequency of use of the religious exemption in New Jersey cases of determination of brain death. PMC6092846. https://pmc.ncbi.nlm.nih.gov/articles/PMC6092846/
• Greer DM, et al. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline (AAN/AAP/CNS/SCCM, 2023). Neurology. 2023. doi:10.1212/WNL.0000000000207740. https://www.neurology.org/doi/10.1212/WNL.0000000000207740
• The 2023 AAN/AAP/CNS/SCCM Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline. Neurology Clinical Practice. doi:10.1212/CPJ.0000000000200189. https://www.neurology.org/doi/10.1212/CPJ.0000000000200189
• The Uniform Determination of Death Act is Being Revised. Neurocrit Care. 2022. PMID 35102538. https://pubmed.ncbi.nlm.nih.gov/35102538/
• Challenges to Brain Death in Revising the Uniform Determination of Death Act: The UDDA Revision Series. PMC10351312 / Neurology, doi:10.1212/WNL.0000000000207334. https://pmc.ncbi.nlm.nih.gov/articles/PMC10351312/
• Jahi McMath case. (Case overview, California declaration 2013; New Jersey transfer; death 2018.) See peer-reviewed analyses, e.g., PMID 34840151. https://pubmed.ncbi.nlm.nih.gov/34840151/
• The Quest to Revise the Uniform Determination of Death Act: Why We Tried, Why We Failed, and Where We Go from Here. Neurocrit Care. 2024. doi:10.1007/s12028-024-01964-w. https://link.springer.com/article/10.1007/s12028-024-01964-w